UPDATE: H.C. Wainwright Downgrades Dova Pharmaceuticals Inc (DOVA) to Neutral
Tweet
Share
E-mailGet Alerts DOVA Hot Sheet
Price: $28.04 --0%
Rating Summary:
4 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
4 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
(Updated - September 30, 2019 10:22 AM EDT)
H.C. Wainwright analyst Joseph Pantginis downgraded Dova Pharmaceuticals Inc (NASDAQ: DOVA) from Buy to Neutral following acquisition with a price target of $27.50 (from $45.00).
For an analyst ratings summary and ratings history on Dova Pharmaceuticals Inc click here. For more ratings news on Dova Pharmaceuticals Inc click here.
Shares of Dova Pharmaceuticals Inc closed at $20.19 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo Downgrades Roku Inc. (ROKU) to Equal Weight
- Shattuck Labs (STTK) PT Lowered to $14 at H.C. Wainwright
- H.C. Wainwright Reiterates Buy Rating on Pharvaris B.V. (PHVS)
Create E-mail Alert Related Categories
DowngradesRelated Entities
Definitive Agreement, H.C. WainwrightSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
